Evidence map›Paper›PMID 41089738›Full record

ArticleJTO clinical and research reports2025

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431].

Marina C Garassino, Shirish Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B Garon, Hidehito Horinouchi, Shunichi Sugawara and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Marina C GarassinoSection of Hematology/Oncology, Thoracic Oncology program, University of Chicago, Chicago, Illinois, and IRCCS Istituto Nazionale dei Tumori, Milano.
Shirish GadgeelDivision of Hematology/Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, Michigan.
Silvia NovelloDepartment of Oncology, University of Turin, Orbassano, Italy.
Balazs HalmosMontefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Enriqueta FelipVall d´Hebron Institute of Oncology (VHIO), Vall d´Hebron University, Barcelona, Spain.
Giovanna SperanzaCentre integré de cancérologie de la Montérégie, Université de Sherbrooke, Greenfield Park, Quebec, Canada.
Rina HuiWestmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
Edward B GaronDavid Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
Hidehito HorinouchiDepartment of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Shunichi SugawaraDepartment of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
Delvys Rodriguez-AbreuComplejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Martin ReckLungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Razvan CristescuMerck & Co., Inc., Rahway, New Jersey.
Deepti Aurora-GargMerck & Co., Inc., Rahway, New Jersey.
Andrey LobodaMerck & Co., Inc., Rahway, New Jersey.
Jared LuncefordMerck & Co., Inc., Rahway, New Jersey.
Julie KobieMerck & Co., Inc., Rahway, New Jersey.
Mark AyersMerck & Co., Inc., Rahway, New Jersey.
Bilal PiperdiMerck & Co., Inc., Rahway, New Jersey.
M Catherine PietanzaMerck & Co., Inc., Rahway, New Jersey.
Luis Paz-AresHospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].

Identifiers

PMID41089738
PMCPMC12515734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.